{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04063501",
            "orgStudyIdInfo": {
                "id": "18-01845"
            },
            "organization": {
                "fullName": "NYU Langone Health",
                "class": "OTHER"
            },
            "briefTitle": "Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer",
            "officialTitle": "Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "longitudinal-evaluation-of-microbial-and-host-signatures-during-immunotherapy-for-lung-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-02-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-08-19",
            "studyFirstSubmitQcDate": "2019-08-20",
            "studyFirstPostDateStruct": {
                "date": "2019-08-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "NYU Langone Health",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will prospectively collect airway, stool, and blood samples on 80 subjects with lung cancer undergoing immunotherapy. Investigators will evaluate airway/stool microbial signatures associated with local (lower airway) and systemic (blood) immune tone.They will then study whether microbiota and/or host signatures predict subjects' response by longitudinal assessment of the progression free survival. They will also repeat sampling after 8 weeks of immunotherapy to expand our mechanistic understanding of the response to treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Lung Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Bacterial DNA will be extracted using an ion exchange column (Qiagen). Microbial DNA samples will potentially be further analyzed for relationships with underlying pathologies as well as to characterize in detail the genetic pool and genetic interactions.."
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Advanced stage unresectable Non-Small Cell Lung Cancer",
                    "description": "Adult patients with a diagnosis of advanced stage unresectable Non-Small Cell Lung Cancer and indication for PD-1 blockade treatment (either as monotherapy or combined with chemotherapy)",
                    "interventionNames": [
                        "Other: Bronchoscopy",
                        "Other: Research Procedures"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Bronchoscopy",
                    "description": "The patient will then return within a week for a research bronchoscopy to sample the upper and lower airways",
                    "armGroupLabels": [
                        "Advanced stage unresectable Non-Small Cell Lung Cancer"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Research Procedures",
                    "description": "electrocardiogram, blood work (CBC, chemistry, coagulation profile and liver function tests, pregnancy test if applicable), X-ray and pulmonary function (spirometry) testing, and provide the patient with a stool collection kit.",
                    "armGroupLabels": [
                        "Advanced stage unresectable Non-Small Cell Lung Cancer"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Progression-free survival (PFS)",
                    "description": "over \u2265 1-year follow-up",
                    "timeFrame": "3 Years"
                },
                {
                    "measure": "Microbiota signatures in lower and upper airways",
                    "timeFrame": "3 Years"
                },
                {
                    "measure": "Microbiota signatures in stool",
                    "timeFrame": "3 Years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients with a diagnosis of advanced stage unresectable Non-Small Cell Lung Cancer and indication for PD-1 blockade treatment (either as monotherapy or combined with chemotherapy)\n\nExclusion Criteria:\n\n* Antibiotic, steroid, or chemotherapy received within the prior month since these are possible confounders that may impact the microbiome and the host immunity.\n* Brain metastasis (as evaluated by MRI obtained as part of standard of care staging evaluation)\n* FEV1\\<50% predicted\n* Cardiovascular disease (defined as abnormal EKG, known or suspected coronary artery disease or congestive heart failure)\n* Renal disease\n* Coagulopathy\n* Liver disease",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "100 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Adult patients with a diagnosis of advanced stage unresectable Non-Small Cell Lung Cancer and indication for PD-1 blockade treatment (either as monotherapy or combined with chemotherapy)",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Lira Gutierrez",
                    "role": "CONTACT",
                    "phone": "212-263-6181",
                    "email": "Lira.Gutierrez@nyulangone.org"
                },
                {
                    "name": "Rosemary Schluger",
                    "role": "CONTACT",
                    "email": "Rosemary.Schluger@nyulangone.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Leopoldo N Segal, MD, MSc",
                    "affiliation": "New York Langone Health",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "N",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Leopoldo Segal, MD, MSc",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                }
            ]
        }
    },
    "hasResults": false
}